Blondel Hazel

Array ( [id] => 2385315 [patent_doc_number] => 04708950 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-11-24 [patent_title] => 'Pharmaceutical composition containing a derivative of orthoaminobenzoic acid as an active ingredient' [patent_app_type] => 1 [patent_app_number] => 6/574533 [patent_app_country] => US [patent_app_date] => 1984-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 13 [patent_no_of_words] => 7425 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/708/04708950.pdf [firstpage_image] =>[orig_patent_app_number] => 574533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2349886 [patent_doc_number] => 04703004 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-10-27 [patent_title] => 'Synthesis of protein with an identification peptide' [patent_app_type] => 1 [patent_app_number] => 6/573825 [patent_app_country] => US [patent_app_date] => 1984-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14598 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/703/04703004.pdf [firstpage_image] =>[orig_patent_app_number] => 573825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2243222 [patent_doc_number] => 04617378 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-10-14 [patent_title] => 'Purification of biologically active human immune interferon' [patent_app_type] => 1 [patent_app_number] => 6/571735 [patent_app_country] => US [patent_app_date] => 1984-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3345 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/617/04617378.pdf [firstpage_image] =>[orig_patent_app_number] => 571735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2296827 [patent_doc_number] => 04696898 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-09-29 [patent_title] => 'Vector encoding hepatitis B surface antigen' [patent_app_type] => 1 [patent_app_number] => 6/570940 [patent_app_country] => US [patent_app_date] => 1984-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2084 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/696/04696898.pdf [firstpage_image] =>[orig_patent_app_number] => 570940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2280054 [patent_doc_number] => 04619828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-10-28 [patent_title] => 'Polysaccharide exotoxoid conjugate vaccines' [patent_app_type] => 1 [patent_app_number] => 6/568453 [patent_app_country] => US [patent_app_date] => 1984-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5739 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/619/04619828.pdf [firstpage_image] =>[orig_patent_app_number] => 568453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2307657 [patent_doc_number] => 04675184 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-06-23 [patent_title] => 'Pharmaceutical composition containing interferon in stable state' [patent_app_type] => 1 [patent_app_number] => 6/568033 [patent_app_country] => US [patent_app_date] => 1984-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3896 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/675/04675184.pdf [firstpage_image] =>[orig_patent_app_number] => 568033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2632936 [patent_doc_number] => 04892743 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-09 [patent_title] => 'Novel hybrid interferon species' [patent_app_type] => 1 [patent_app_number] => 6/564066 [patent_app_country] => US [patent_app_date] => 1983-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5060 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/892/04892743.pdf [firstpage_image] =>[orig_patent_app_number] => 564066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2156032 [patent_doc_number] => 04518584 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1985-05-21 [patent_title] => 'Human recombinant interleukin-2 muteins' [patent_app_type] => 1 [patent_app_number] => 6/564224 [patent_app_country] => US [patent_app_date] => 1983-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 11062 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/518/04518584.pdf [firstpage_image] =>[orig_patent_app_number] => 564224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2385036 [patent_doc_number] => 04695623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-09-22 [patent_title] => 'Consensus human leukocyte interferon' [patent_app_type] => 1 [patent_app_number] => 6/560495 [patent_app_country] => US [patent_app_date] => 1983-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15848 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/695/04695623.pdf [firstpage_image] =>[orig_patent_app_number] => 560495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2411014 [patent_doc_number] => 04731238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-03-15 [patent_title] => 'Novel monoclonal hybridoma and corresponding antibody' [patent_app_type] => 1 [patent_app_number] => 6/558538 [patent_app_country] => US [patent_app_date] => 1983-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5911 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/731/04731238.pdf [firstpage_image] =>[orig_patent_app_number] => 558538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2143808 [patent_doc_number] => 04536391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1985-08-20 [patent_title] => 'Process for preparing urokinase complex' [patent_app_type] => 1 [patent_app_number] => 6/551841 [patent_app_country] => US [patent_app_date] => 1983-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 15161 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/536/04536391.pdf [firstpage_image] =>[orig_patent_app_number] => 551841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2410989 [patent_doc_number] => 04731237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-03-15 [patent_title] => 'Immune response to virus induced by anti-idiotype antibodies' [patent_app_type] => 1 [patent_app_number] => 6/549506 [patent_app_country] => US [patent_app_date] => 1983-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4626 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/731/04731237.pdf [firstpage_image] =>[orig_patent_app_number] => 549506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2302172 [patent_doc_number] => 04643992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-02-17 [patent_title] => 'Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives' [patent_app_type] => 1 [patent_app_number] => 6/546679 [patent_app_country] => US [patent_app_date] => 1983-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 32 [patent_no_of_words] => 20636 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/643/04643992.pdf [firstpage_image] =>[orig_patent_app_number] => 546679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2178278 [patent_doc_number] => 04507281 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1985-03-26 [patent_title] => 'Interferon-containing compositions' [patent_app_type] => 1 [patent_app_number] => 6/546573 [patent_app_country] => US [patent_app_date] => 1983-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3486 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/507/04507281.pdf [firstpage_image] =>[orig_patent_app_number] => 546573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2322806 [patent_doc_number] => 04636384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-01-13 [patent_title] => 'Method for treating disorders of the vascular and pulmonary systems' [patent_app_type] => 1 [patent_app_number] => 6/546162 [patent_app_country] => US [patent_app_date] => 1983-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 7297 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/636/04636384.pdf [firstpage_image] =>[orig_patent_app_number] => 546162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2117173 [patent_doc_number] => 04488991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1984-12-18 [patent_title] => 'Bacterial toxoids and gram-negative immune globulin therefrom' [patent_app_type] => 1 [patent_app_number] => 6/545565 [patent_app_country] => US [patent_app_date] => 1983-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5038 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/488/04488991.pdf [firstpage_image] =>[orig_patent_app_number] => 545565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2312820 [patent_doc_number] => 04699783 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-10-13 [patent_title] => 'Products and methods for treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 6/542239 [patent_app_country] => US [patent_app_date] => 1983-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 19137 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/699/04699783.pdf [firstpage_image] =>[orig_patent_app_number] => 542239 [rel_patent_id] =>[rel_patent_doc_number] =>)